Neurology® Podcast

  • Author: Vários
  • Narrator: Vários
  • Publisher: Podcast
  • Duration: 514:09:49
  • More information

Informações:

Synopsis

The Neurology podcast is introduced by Editor-in-Chief Robert A. Gross, MD, PhD, who discusses several highlighted articles in the current issue of Neurology®. The podcast regularly features content from Neurology® Clinical Practice, Neurology® Genetics, and Neurology® Neuroimmunology & Neuroinflammation. Opening segments include interviews with authors who summarize a current article and discuss the main findings and clinical implications for neurologists. Regular features also include the Lesson of the Week, Delayed Recall, Whats Trending, and selected content from Neurology® Today. Podcast listeners can earn 0.5 AMA PRA Category 1 CME Credits by answering the multiple-choice questions related to Neurology content in the online Podcast Quiz. (Delayed Recall, Neurology® Clinical Practice, Neurology® Genetics, and Neurology® Neuroimmunology & Neuroinflammation contents are excluded from the CME program). The exams are posted weekly on Tuesday.

Episodes

  • July 16 2013 Issue

    15/07/2013 Duration: 26min

    1) Development and validation of a clinical guideline for diagnosing blepharospasm and 2) Topic of the month: AAN Plenary Sessions. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Binit Shah interviews Dr. Giovanni Defazio about his paper on development and validation of a clinical guideline for diagnosing blepharospasm. Dr. Roy Strowd is reading our e-Pearl of the week about iatrogenic botulism. In the next part of the podcast Dr. Alberto Espay interviews Dr. Salvatore DiMauro about his Robert Wartenberg Lecture on Mitochondrial encephalomyopathies: 50 years on. The participants had nothing to disclose except Drs. Defazio, Strowd, Espay and DiMauro.Dr. Defazio receives research support from the Italian Ministry of University and Comitato Promotore Telethon.Dr. Strowd serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Espay is suppo

  • July 9 2013 Issue

    08/07/2013 Duration: 31min

    1) Surveillance neuroimaging and neurologic examinations affecting care for intracerebral hemorrhage and 2) Topic of the month: AAN Plenary Sessions. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Mike Brogan interviews Dr. Matthew Maas about his paper on surveillance neuroimaging and neurologic examinations affecting care for intracerebral hemorrhage. Dr. Roy Strowd is reading our e-Pearl of the week about dopamine dysregulation syndrome in Parkinson disease. In the next part of the podcast Dr. Alberto Espay interviews Drs. Stephen Reich and C. Warren Olanow on levodopa being initiated at time of diagnosis of movement disorders. The participants had nothing to disclose except Drs. Maas, Strowd, Espay, Olanow and Reich.Dr. Maas receives research support from the NIH.Dr. Strowd serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Espa

  • July 2 2013 Issue

    01/07/2013 Duration: 38min

    1) Depressive symptoms and white matter dysfunction in retired NFL players with concussion history and 2) Topic of the month: AAN Plenary Sessions. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Christopher Giza interviews Dr. John Hart about his paper on depressive symptoms and white matter dysfunction in retired NFL players. Dr. Adam Numis is reading our e-Pearl of the week about ice-cream headache. In the next part of the podcast Dr. Alberto Espay interviews Drs. Ron Postuma and Brad Boeve about clinicopathologic correlations in 172 cases of REM sleep behavior disorder. The participants had nothing to disclose except Drs. Giza, Hart, Numis, Espay, Postuma and Boeve.Dr. Giza serves on the data safety monitoring board for LAbiomed Institute at Harbor-UCLA Medical Center; is a consult for NHL Player's Association; serves on the speakers' bureau for the Medical

  • Delayed Recall - July 2013 - Stroke Update 2013

    01/07/2013 Duration: 43min

    Stroke Update 2013

  • June 11 2013

    10/06/2013 Duration: 25min

    1) Guideline update: Evaluation and management of concussion in sports and 2) Topic of the month: AAN Plenary Sessions. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Howard Goodkin interviews Christopher Giza about this guideline update on evaluation and management of concussion in sports. Dr. Adam Numis is reading our e-Pearl of the week about anti -MuSK antibody myasthenia gravis. In the next part of the podcast Dr. Alberto Espay interviews Dr. Merit Cudkowicz about her plenary session on ALS pathways to treatments. The participants had nothing to disclose except Drs. Goodkin, Giza, Numis, Espay and Cudkowicz.Dr. Goodkin serves as an editorial board member of Neurology and Surgical Neurology International; receives royalties from Up-to-Date for co-authorship of The Choking Game and other strangulation activities in children and adolescents; receives research

  • June 4 2013 Issue

    03/06/2013 Duration: 27min

    1) Creation of the AAN Global Health Section and 2) Topic of the month: AAN Plenary Sessions. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Farrah Mateen interviews Dr. Amy Lee about her paper on the creation of the AAN Global Health Section. Dr. Adam Numis is reading our e-Pearl of the week about Tullio phenomenon. In the next part of the podcast Dr. Alberto Espay interviews Dr. Jerome Posner about receiving the 2013 President's Award at the AAN Meeting and discussing his lecture on the importance of teaching and mentoring in neurology. The participants had nothing to disclose except Drs. Mateen, Numis, Espay and Posner.Dr. Mateen has consulted for the World Health Organization, Global Polio Eradication Initiative, and Caritas.Dr. Numis serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Espay is supported by the K23 career develo

  • Delayed Recall - June 2013 - Cerebellar Ataxias II

    01/06/2013 Duration: 53min

    Genetic causes of ataxia

  • May 28 2013 Issue

    27/05/2013 Duration: 20min

    1) Evidence-based guideline on periprocedural management of antithrombotic medications and neurovascular disease and 2) Topic of the month: Treatment of movement disorders. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Andy Southerland interviews Dr. Melissa Armstrong about the guideline on periprocedural management of antithrombotic medications and neurovascular disease. Dr. Roy Strowd is reading our e-Pearl of the week about HINTS of stroke. In the next part of the podcast Dr. Binit Shah interviews Dr. Kapil Sethi about management of of non-dopa responsive axial motor symptoms. The participants had nothing to disclose except Drs. Armstrong, Strowd and Sethi.Dr. Armstrong serves on Neurology, Level of Evidence Review Team; received funding for a trip to the MDS International Congress; received research support from Abbott and was partially funded by a Edmond

  • May 21 2013 Issue

    20/05/2013 Duration: 26min

    1) Growing burden of neurodegenerative conditions and 2) Topic of the month: Treatment of movement disorders. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Binit Shah interviews Dr. Ray Dorsey about his paper on obtaining care for the growing burden of neurodegenerative conditions. Dr. Roy Strowd is reading our e-Pearl of the week about Huntington disease and the milk maid grip. In the next part of the podcast Dr. Binit Shah interviews Dr. Michael Okun about surgical management of Parkinson disease. The participants had nothing to disclose except Drs. Dorsey and Strowd.Dr. Dorsey serves on the scientific advisory board for Lundbeck Inc. and Huntington's Disease Society of America; serves as an editorial board member of Journal of Huntington's Disease; is a consultant for Avid Radiopharmaceuticals, Inc., Clintrex, Lundbeck, Inc., Medtronic, Inc., National Insti

  • May 14 2013 Issue

    13/05/2013 Duration: 19min

    1) MRI sign of progressive supranuclear palsy and 2) Topic of the month: Treatment of movement disorders. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. John Morgan interviews Dr. Luke Massey about his paper on an MRI sign of progressive supranuclear palsy. Dr. Roy Strowd is reading our e-Pearl of the week about the hummingbird sign. In the next part of the podcast Dr. Matthew Barrett interviews Dr. Fred Wooten about late treatment of motor symptoms. The participants had nothing to disclose except Drs. Morgan, Massey and Strowd.Dr. Morgan is a consultant for Impax Laboratories, Inc. and Veloxis Pharmaceuticals; serves on the speakers' bureaus of GlaxoSmithKline, Teva Pharmaceuticals Industries Ltd., UCB and GE Healthcare; performed CME for Oakstone Publishing, LLC; receives research support from the NIH and received compensation for review of medical records an

  • May 7 2013 Issue

    06/05/2013 Duration: 24min

    1) Diagnosis of gluten ataxia and 2) Topic of the month: Treatment of movement disorders. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Matthew Barrett interviews Dr. Marios Hadjivassiliou about his paper on the diagnosis of gluten ataxia. Dr. Roy Strowd is reading our e-Pearl of the week about tonic spasms in multiple sclerosis. In the next part of the podcast Dr. Matthew Barrett interviews Dr. Fred Wooten about early treatment of motor symptoms. The participants had nothing to disclose except Dr. Strowd.Dr. Strowd serves on the editorial team for the Neurology® Resident and Fellow Section.

  • Delayed Recall - May 2013 - Cerebellar Ataxias I

    01/05/2013 Duration: 33min

    Immune mediated, toxic & infectious ataxias

  • April 30 2013

    29/04/2013 Duration: 21min

    1) Exposure to stroke belt on incident stroke and 2) Topic of the month: Stroke trials. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Andy Southerland interviews Dr. Virginia Howard about her paper on exposure to the stroke belt on incident stroke in adulthood. Dr. Adam Numis is reading our e-Pearl of the week about Neuro-Behcet's disease. In the next part of the podcast Dr. Brett Kissela focuses his interview with Dr. Chelsea Kidwell about the MR Rescue trial. The participants had nothing to disclose except Drs Howard, Numis, Kissela and Kidwell.Dr. Howard serves on DSMB for NIH-NIDA; is a consultant for NIH review committees and receives research support from the NIH.Dr. Numis serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Kissela serves on scientific advisory board for Allergan, Inc.; has received funding for travel and spe

  • April 23 2013

    22/04/2013 Duration: 23min

    1) Atrial fibrillation and unexplained stroke and 2) Topic of the month: Stroke trials. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Bryan Eckerle interviews Dr. Paul Cotter about his paper on incidence of atrial fibrillation and unexplained stroke. Dr. Adam Numis is reading our e-Pearl of the week about LGI-1 antibodies in limbic encephalitis. In the next part of the podcast Dr. Brett Kissela interviews Drs. Opeolu Adeoye and Art Pancioli about the CLEAR-ER trial. The participants had nothing to disclose except Drs Cotter, Numis, Kissela and Adeoye.Dr. Cotter receives research support from the UK National Institute for Health Research, Cambridge biomedical Research Center and Clinical Research Fellowship.Dr. Numis serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Kissela serves on scientific advisory board for Allergan, Inc.; h

  • April 16 2013 Issue

    15/04/2013 Duration: 31min

    1) Human herpes 6 virus encephalitis and 2) Topic of the month: Stroke trials. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Joanna Jen interviews Dr. Mina Bhanushali and Sarah Kranick about their paper on human herpes 6 virus encephalitis and stem cell transplantation. Dr. Adam Numis is reading our e-Pearl of the week about ictal syncope. In the next part of the podcast Dr. Brett Kissela interviews Dr. Clay Johnston about CHANCE trial. All the participants have disclosures.Dr. Jen serves as an Associate Editor of Frontiers in Neuro-otology and Section Editor of Experimental Brain Research and receives research support from the FDA.Ms. Kranick is a staff member of the National Institute of Health.Dr. Bhanushali Is an employee of the National Institute of Health.Dr. Numis serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Kissela s

  • April 9 2013 Issue

    08/04/2013 Duration: 31min

    1) PML diagnostic criteria: Consensus statement from AAN Neuroinfectious Disease Section and 2) Topic of the month: Stroke trials. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Andy Southerland interviews Dr. Joseph Berger about the consensus paper from the PML Guidelines Committee of the AAN Neuroinfectious Disease Section. Dr. Andy Numis is reading our e-Pearl of the week about spinal epidural abscesses. In the next part of the podcast Dr. Brett Kissela interviews Dr. Marc Chimowitz about SAMMPRIS trial. The participants had nothing to disclose except Drs. Berger, Numis, Kissela and Chimowitz.Dr. Berger serves as an Associate Editor for the Journal of Neurovirology, serves as an editorial board member of ISRN Education, Neuroscience, World Journal of Rheumatology and MS and other related disorders; serves on the PML adjudication committees of Millenium/Taked

  • April 2 2013 Issue

    01/04/2013 Duration: 22min

    1) NMO spectrum and MS brain lesion and 2) Topic of the month: Stroke trials. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Mark Keegan interviews Dr. Lucy Matthews about her paper on seropositive NMO spectrum disorder and MS brain lesion distribution. Dr. Adam Numis is reading our e-Pearl of the week about intravascular B-cell lymphoma. In the next part of the podcast Dr. Brett Kissela interviews Dr. Joseph Broderick about IMS III trial. All the participants have disclosures.Dr. Keegan serves as Chief Editor for eMedicine; is a consultant for Bionest and Novartis. Dr. Matthews receives research support from UK Medical Research Council and is funded by the Clinical Research Training Fellow ship.Dr. Numis serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Kissela serves on scientific advisory board for Allergan, Inc.; has received

  • Delayed Recall - Apr 2013 - Encephalopathy of Systemic Disease II

    01/04/2013 Duration: 27min

    Encephalopathies caused by drugs, vitamins, infectious and autoimmune disorders

  • March 26 2013 Issue

    25/03/2013 Duration: 32min

    1) Preclinical Alzheimer disease and 2) Topic of the month: Cerebellar ataxias. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Jeff Burns interviews Prof. Michael Ewers about his paper on preclinical Alzheimer disease. Dr. Stacey Clardy is reading our e-Pearl of the week about neurologic symptoms in relapsing polychondritis. In the next part of the podcast Dr. Ted Burns interviews Drs. Susan Perlman and Jeremy Schmahmann about the topic of inherited ataxias and sporadic, degenerative ataxias. In concluding, there is a brief statement where to find other up-to date patient information and current Patient Page. The participants had nothing to disclose except Drs Jeff Burns, Ewers, Clardy, Ted Burns, Perlman and Schmahmann.Dr. Jeff Burns serves on the editorial board for Journal of Alzheimer's Disease; receives royalties for the publications of Early diagnosis and

  • March 19 2013 Issue

    18/03/2013 Duration: 28min

    1) Niemann-Pick type C and 2) Topic of the month: Cerebellar ataxias. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Ted Burns interviews Dr. Matthis Synofzik about his paper on Niemann-Pick type C. Dr. Stacey Clardy is reading our e-Pearl of the week about cephalic tetanus. In the next part of the podcast Dr. Ted Burns interviews Drs. Susan Perlman and Jeremy Schmahmann about the topic of inherited ataxias. The participants had nothing to disclose except Drs Burns, Synofzik, Clardy, Perlman and Schmahmann.Dr. Burns serves as Podcast Editor for Neurology®; and has received research support for consulting activities with CSL Behring and Alexion Pharmaceuticals.Dr. Synofzik receives honoraria from Actelion Pharmaceuticals; receives travel funding from Movement Disorders Society and receives research support from the Volkswagen Foundation.Dr. Clardy served on the

page 44 from 59